Reddit Posts
2 “Strong Buy” Penny Stocks With Over 400% Upside on the Horizon
Rockets that are loaded: STAB, CYRN, SATL, DRTS, SKYH, CYN, BWV, MLTX, PTPI, ALLG
$THCA - Low Float SPAC near NAV, with squeeze potential
Real Potential $ISPO 2.0 -- $DRTS Moon shot incoming!
DRTS is an early candidate to a squeeze!! Buy now get paid in a week.
$DRTS Annual Report “In Coming Days” Will include share breakdown
Mentions
Hey, not OP but just recently got into DRTS from other folks on this board. Right now they have a negative EPS because they are pre-revenue. Typically biotech stocks have a long period of time while they’re undergoing clinical trials to demonstrate effectiveness and receive approval for commercial use in various markets. Fortunately for us, Alpha Tau (DRTS) is close to commercialization in a handful of markets and has received “Breakthrough Therapy” designation in the US. This means that their solution is so promising for cancer that the US is willing to fast-track trials and potentially approvals. While we still won’t see revenue until 2026 most likely, they have a number of short and mid-term positive catalysts that could boost the price. They’re awaiting marketing authorization in Japan, and once / if approved that should start driving revenue. We expect to see this sometime in the next month or so. Additionally, they have a US based facility that’s nearing completion and will be operational in 2026, along with the results from the first Pancreatic Cancer patient in the US. IMO, this news is most likely to boost the price in the short term. I’m very bullish on this company. Right now its biggest weakness is that it’s almost completely unknown in the investor space, and management is not focused on growing the stock price. They’re focused on hard science and delivering results, with the philosophy that the price will follow. Companies in a similar stage of development are being bought out by competitors for $1-$3B, which would be a 3-10x from current market cap. I believe DRTS wished to remain independent, which leaves huge potential for outsized growth. Do your own DD, but there is a very asymmetric risk / reward play here. While their EPS is negative, they’re extremely diligent in their cash management, and are funded for 2 years. This significantly minimizes downside risk
Don’t have my daily/weekly plays down yet, but if you’re looking for a play to settle into a bit longer with high upside - DRTS
Picked up some DRTS at open, still hovering around my entry price ($4.21)
What about DRTS? I'm open to new ideas
If you’re looking for new stocks I’d love to tell you about DRTS if you’re interested
You could see the DRTS daily PL, the other numbers are for the whole portfolio. I don’t usually share any of this but it seemed to be important to you so I shared the relevant numbers. I don’t understand what you’re accusing me of, what do I have to hide? Also the stock could be a great investment regardless of my position, the data and info are public…
Great job, don’t miss DRTS as well!
Hey, DRTS is my favorite stock in the portfolio TL;DR it’s a company with a revolutionary cancer treatment that actually works, does no harm to the body and is effective against even the hardest tumors It has financial runway through commercialization, a lot of FDA progress, expecting PMDA approval before EOY and has some more big catalysts coming The only thing it’s missing is retail awareness (even you holding the stock didn’t really know about it), and therefore it’s a huge opportunity to make millions of dollars with the company aiming to saves millions of lives
The only penny stock I have this week that is up is a little thing called DRTS. I am out with friends but if anyone has research on this stock feel free to share. Otherwise I'll do some research tomorrow
DRTS for anyone hoping to become one this year
Sure, it’s a company with a revolutionary cancer treatment, internal data showing promise to treat even the hardest tumors, already very advanced in FDA trials with outstanding results, great financial runway and already building manufacturing factory yet still very under the radar. I’d love to elaborate even more if you’d like. Could also check out my recent post about the upcoming catalyst of DRTS: https://www.reddit.com/r/pennystocks/s/ynT7MmSit6
I get what you’re saying, but I think you’re brushing over some key risks here. PMDA approval would be a great milestone, but let’s be real: Japan is a much smaller market compared to the U.S. or EU. Without FDA/EMA approval, you’re not looking at huge revenues yet, and big pharma tends to dominate until you’ve got a clear superiority case. On competition yes, sadly there’s plenty of cancer to treat, but that doesn’t mean every biotech wins. The barrier isn’t just “demand exists,” it’s about proving your therapy is either better or complementary enough to grab market share. Otherwise the giants will eat your lunch. I mean look at Novo Nordisk and Lly. They are like the only real competition and others don't get really a chance. I’m not saying DRTS has no future, but until we see Phase 3 readouts and meaningful approvals, this is still very much speculative. Even though I'm already in that stock invested but until no influential catalyst I will not go all in. You reddit users tend to Exaggerate small things. And when playing with that money I would say, keep it realistic.
Join me at DRTS, too much to love and it’s only the very beginning
Many good options, but if you want a real gem that is just under everyone’s radar (but not for long) - DRTS.
Bullish DRTS, can’t believe it still isn’t getting mentioned with all the major catalysts coming (PMDA, GBM, Pancreas, Factory etc etc)
Can’t wait for DRTS to be a community favorite as well
DRTS long - major catalysts coming
DRTS - major catalysts coming feel free to ask
Many are wary of Biotech, but just as all stocks it just needs the right research and situation. In short, DRTS is a life saving treatment, the company has the financial runway to execute, already has FDA breakthrough device designation and many more clinical and regulatory needs cleared, they are already treating patients in the US as part of the FDA IDE they have for multiple tumor types, the only thing lacking is awareness making it a under the radar play - with major catalysts coming as soon as this year (PMDA approval in Japan, GBM patient, Commercialization efforts, Strategic partnership deals…)
People look at this stock as pre-revenue (as it is), but there are Billions in profit just waiting to be claimed by DRTS the moment the treatment gets approved while they are crushing the trials and have the financial runway to execute with ease
It’s inevitable that the tools will be used (and then everything will be geared toward gaming the tools including company statements etc and the whole industry will change accordingly) but I believe we aren’t there yet, and even when we do get there being able to DYOR will be where the opportunity lies. For example DRTS is under all radars and wouldn’t get detected in any AI tool or algorithm, but those who understand and invest will win big when it eventually surfaces.
Can’t wait for DRTS to be part of the community favorites
DRTS long - some major catalysts on the way (FDA approved Pancreatic Cancer treatments, GBM, PMDA approval in Japan and more…)
Love the question, many people treat penny stocks as meme stocks, while the truth is there is real world changing value waiting to be discovered (with the right research and risk tolerance). DRTS is a revolutionary cancer treatment with major catalysts coming up. I’d love to write more about it if anyone is interested.
Alpha Tau Medical - DRTS
DRTS has some big catalysts coming up, the 6 month chart will tell you all you need to know https://preview.redd.it/k30btdowc9pf1.jpeg?width=1290&format=pjpg&auto=webp&s=326b90be6483efd380aa2d4d70c2ab2c53d5d1b2
DRTS is pre revenue but expecting PMDA approval in Japan before EOY. That’s a multi billion dollar life saving market. Has successfully treated a Pancreatic Cancer patient in the US as well, securing FDA breakthrough device designation and getting accepted into the FDA TAP program that is essentially a fast track to market.
Every day we get closer to the PMDA approving DRTS in Japan, followed by many FDA catalysts in the US
DRTS is loading (PMDA approval upcoming)
Always good to have great community members learning together. If you want an interesting stock to look into - DRTS
DRTS is a must have on all lists going forward I’d love to make the case for anyone interested to hear it
There is a formula on how to hit big. It demands real research and risk tolerance. Remember this comment when DRTS makes people millions.
Hey Azriel, welcome to DRTS! The reason this is happening might be restrictions by your broker or limitations on your account. Some brokers/account types won’t trade some kind of stocks, depending on all kinds of metrics for example the price (say under 5$). To resolve you could contact the broker and get approval to trade DRTS. Also make sure the order type and available funds and everything else is valid and correct.
Yessir, conviction (when earned by research and backed by risk tolerance) is the way to win! Hopefully many in the community will be posting the same with DRTS soon
At this point ignore DRTS at your own cost
Ask the chat about DRTS👀
Definitely look into DRTS. It’s been moving nicely and for the right reasons. I’d love to elaborate if you’re interested. https://preview.redd.it/a35l1g3974of1.jpeg?width=1065&format=pjpg&auto=webp&s=615b9e7cca93d81189fdfe1d81f31e7d504ef713
Thanks for sharing! Be sure to check out DRTS as well, interested to hear what you’ll find
DRTS is moving nice and steady, they are presenting today at the H.C. Wainwright 27th Annual Global Investment Conference
In most cases it’s priced in, but with some stocks they could go under the radar and therefore be undervalued until discovered. For example I think DRTS could go as high as 10$ with no new catalysts only off discovery.
DRTS is expecting PMDA approval in Japan for their life saving cancer treatment before EOY
Here’s a stock I’ve done plenty of research on, have been following for a long while and invested plenty into - DRTS. This is the most recent news: https://www.reddit.com/r/pennystocks/s/NhE8cMn58k And this is a full DD: https://www.reddit.com/r/pennystocks/s/lHrkVbRh4G This is one you’ll enjoy holding, it’s got the strongest fundamentals and the potential is massive…
My favorite pick is DRTS. The stock already has: - FDA breakthrough device designation - FDA TAP program inclusion - FDA MDSAP certification - FDA IDE’s for several cancers - FDA trials (multiple) at phase 2 and 3 - Financial runway beyond commercialization - 2 manufacturing factories built and a 3rd and largest being built in the US - 100% tumor response rate in early FDA trials - Could treat high unmet needs cancers like Pancreatic, Lungs, Brain, Breast, etc… - Activates immune system response - 50+ clinical sites worldwide (including USA, UK, Canada, France, Germany, Russia, etc…) - Patents, IP and more… This week they successfully initiated the IMPACT study by treating the first Pancreatic Cancer patient in the US, after successfully completing their trials with over 40 Pancreatic Cancer patients in Canada. Furthermore they are expecting PMDA approval in Japan this calendar year. One of the most undervalued plays in a multi hundred billion dollar life saving market.
DRTS - Alpha Tau Successfully Treats First Patient in its U.S. Multi Center Pancreatic Cancer Clinical Trial
Big Pharma will more likely buy it (or sign an exclusive strategic partnership), with the last M&A’s in the sector ranging between 1-6 Billion which is a 10X for DRTS
Highly recommend doing DD on Alpha Tau (DRTS), it’s fundamentally unbelievable (and only place I’ve really seen it mentioned is this sub)
$IXHL for being a short-term and long-term play. Buy as early as possible; sell the news. When it dips / crashes / dilutes trends back down, buy again and await Phase 3. $CHRS is very likely to see a squeeze early next week, as a huge and careless short float is facing a massive earnings-per-share increase due to a proprietary sale. $ADIL has c. 60% odds of FDA approval on Tuesday; it will rally until then, but potentially crash if the FDA doesn't deliver. $DRTS has drugs to treat difficult-to-treat cancers, 100% effective in clinical trials to date. It will be an absolute machine if it tears off. $UURAF and $ARRNF are both rare earths miners, though $ARRNF is at the exploratory stage with unusually large extraction rates for certain rare earths and $UURAF owns an efficiency-boosting patented tech (very useful for getting it through the unprofitable opening phases of mining; unusually strong survivability).
Best one I’ve seen in the sub lately is $DRTS
$1 of gold ;) Or, if you insist on stocks, UURAF. Rare earths miner with patented efficiency tech. Currently $1.40 (actually $1.36 but it'll be $1.40+ before anything opens on Monday). ARRNF is a cheaper player in the same field. It's strength is the extraction rate of particular rare earths and the sheer size of its Halleck Creek site. It doesn't yet have an operational mine and I think it's still at minor risk of dilution. IXHL has 10x potential, *if* its currently-trialled drug maintains its use case - side-effect free sleep apnea treatment - in larger Phase 2 studies (about which we're awaiting imminent news). I personally would not buy at this price unless you plan to sell the news and buy back in when the price drops, because so much of the volume is hype-chasers also selling the news and the company itself is likely to dilute to fund Phase 3. Sellas Life Sciences is another late-clinical phase cancer-fighting biotech, but if it's too expensive (at $1.83) then Alpha Tau (DRTS) is another I've seen recommended - though I haven't done due diligence on it.
DRTS - 100% tumor response cancer treatment, lethal to cancer cells while sparing healthy tissue, could treat high unmet need cancers like Pancreatic cancer. Really recommend checking it out, phase 3 FDA already and totally under the radar
Add DRTS to the watchlist, might not run today but it’s worth the DD so you are ready when it does run
DRTS has everything in place. It’s a matter of months until it’s 10-20X. The moment retail discovers it or an approval comes in (that’s coming in the coming months) it will take off and could start any day really
Of course nobody has only wins, but u/pristine_hurry_4693 has given me BBAI at 2.71, OBIO that moved a bit, MRVI that is down this week but he’s been onto it since about 2$, SRFM, said CMPS will bounce back after it recently got cut in half, ATAI which is the same category, he got me onto Quantum, he’s been preaching Bitcoin since 34K (at least that’s when I heard it from him), I got the CYN run and MLGO (even though that one I miss timed), you get the point… of course I use my own discretion and lately he’s harping on DRTS only, but he’s good
DRTS might be one of the least known with one of the highest ceilings
Accumulating DRTS before it runs
DRTS has an exclusive investor virtual event today at 1 PM ET: https://rebrand.ly/sxt521k
DRTS has an exclusive investor event online on Monday
For sure, it’s a game of risk management. And if you’d like to check out DRTS, they’re holding an exclusive investor virtual event on Monday so that might be a good place to start. Here’s a link to the YouTube stream: https://rebrand.ly/sxt521k
Now I’m going to want to check out DRTS… 🧐
Yessir love the energy, I have a stock I feel the same about, the no-PR-and-no-retail but have conviction story [DRTS]. So I 100% understand it and see the vision and potential here
Next week DRTS might pop up with the Exclusive Investor Webinar
The daily DRTS reminder
I’ll keep dropping DRTS so hopefully it sparks your interest
Hope everyone has a great day, as usual noting DRTS is a stock to watch
The ticker is $DRTS. It’s a company with a revolutionary cancer treatment, can treat high unmet needs, with 100% tumor response in early FDA clinical trials. They are already in phase 3 of their FDA trials. They also have the FDA’s breakthrough device designation. Are part of the FDA’s TAP program. Have MDSAP certification. And more… all to allow them to get to market ASAP. They are also expecting PMDA approval in Japan this quarter. They have 90+ million dollars, way more than needed to get to commercialization. Three factories (2 in the US) ready to manufacture. All tech is patented. They are treating patients (through trials) in 50+ clinical sites worldwide (US, UK, France, Russia, Japan, Canada…) There’s a lot to like with a multibillion dollar market, and almost no retail interest making it under the radar and undervalued.
Nice job community, we got our Lounge back. Thanks to the Mods as well. I’ll just drop DRTS as a stock that should be added to the watchlist.
Did yours in case they remove this tonight. Last one for today. **DRTS** I gotta say, I like this chart strength. Despite the flat, low volume close on Thursday, SUPER clean uptrend past 7 days, took back MA20/50/200, and a high that was approaching major breakout zone (if breaks out, would need realllll nice volume to squeeze to $3.40-3.50). BUT, the dilution overhang just cleared (F-3, 3.5M share resale effective Thursday) so without volume coming in Monday this thing could stall as holders slowly sell. Howevern, the EFFECT is definitely already priced in so might be looked at as a "clean slate". Be aware that although this is low float it's also low liquidity so it probably have to get big attention somehow, and remember to keep risk TIGHT on low liquids. Look for PM volume >100k while holding above $3.08 aka MA20 reclaim. Need to see buyer control via price above VWAP. If it passes $3.17ish PM with solid volume (20k+ on 1m candles), strong sign of momentum. If it doesn't test $3.17 PM, look for it around open with volume >150k by 935 (bullish). Expect 935-945 dip towards VWAPish $3.08-3.12. If it holds and reverses, might be your starter entry (in a perfect world $3.05). 945-1000 if bullish as described above, price reclaims $3.25-3.30 with volume toward +250k (with matching higher lows), your breakout would be something like $3.40. Gnight everyone!
I have a diversified stock portfolio(s), real estate, bitcoin and many years of experience, but there is one stock that is my favorite of them all and I have strong conviction and high hopes for. The ticker is DRTS, I’d love to share more about it if you’re interested
Always amazed how unknown DRTS is
My best play is $DRTS. Usually the bigger the reward so it the risk, therefore many will miss real gains even when they hit. This stock is in a once in a lifetime position imho. With a market cap of only ~250M, the company has 90M+ cash, three factories, patented tech, FDA breakthrough device designation, FDA TAP program, FDA IDE’s, MDSAP certification and much more. One could argue the stock is fundamentally worth today more than the 3$ it’s trading at (even if no further approvals are granted). They have many FDA approved clinical trials going on, some in phase 2 and 3 already. They also past all the PMDA appliances and are expected approval in Japan this quarter. Their product is a new cancer treatment, with early clinical results showing 100% tumor response. The treatment (Alpha DaRT) can shrink tumors and make them disappear even in unmet needs cases. The treatment also showed a systemic immune response. I’d love to share more all about it if anyone would like to hear. The reason it isn’t trading around 10$ (already now, and could go much higher of course with the PMDA expected approval and then FDA and US commercialization in H1 2026) is because it has 0 PR and 0 retail exposure.
I commented on your post yesterday before opening bell and before it got removed I had CYN which ran up over 500% at one point I had BBAI that’s having an amazing run itself, with a cool 20% yesterday And DRTS which isn’t immediate but is my favorite for the coming months Probably my best Lounge comment ever😄
I like BBAI Other than that CMPS showed a start of a comeback after getting cut in half this week CYN spiked as it tends to do lately between 4 and 5 And not necessarily short term but I’m holding DRTS with strong conviction and high hopes
$DRTS is expected FDA approval in Q1 2026, but PMDA Approval in Japan this Q. Here’s the DD: https://www.reddit.com/r/pennystocks/s/CHkMEE6dvO
Love the breakdown, thanks for sharing! I just answered your former comment and seeing this now. Worth noting $DRTS already: - Received FDA Breakthrough Device Designation - Got accepted into the FDA's Total Product Life Cycle Advisory Program (TAP) - Achieved MDSAP (Medical Device Single Audit Program) certification - Received FDA approval for an Investigational Device Exemption (IDE) - Is expecting PMDA approval in Japan this quarter - Is in phase 3 of FDA approved trials and has many more trials in other phases
Interesting... Me:Actually speaking of dart... if it works as my theory laid out wouldn't it be at high likelihood of getting fda approval? Chatgpt: Yup — if your theory holds up, FDA approval becomes a lot more likely. Here's why, broken down by logic and how the FDA thinks: 🧠 Your Theory Recap: Alpha DaRT strips electrons from DNA → double-strand breaks → triggers immune attention → possible reactivation of p53 pathways → localized tumor death → no systemic toxicity. 🔍 What the FDA cares about: PriorityWhat They Look ForDoes Alpha DaRT Fit?✅ EfficacyDoes it shrink or eliminate tumors?Yes, 100% response rate in early trials (solid tumors)✅ SafetyDoes it harm healthy tissue?No, alpha particles are highly localized, minimal side effects✅ MechanismIs the logic of action well-understood?Yes, known radiation biology; alpha particles = lethal, but short-range✅ ScalabilityCan it be used in real-world settings?Appears to be yes — implantable seeds, like brachytherapy⚠️ Manufacturing/QACan it be consistently produced and handled?TBD — radioisotope handling can be tricky⚠️ Long-term dataAny signs of recurrence or secondary issues?Still in trial, so unknown — but initial signs are strong 🔥 Why This May Be Fast-Tracked: Treats tumors that are otherwise untreatable May qualify for: Breakthrough Therapy designation Accelerated approval Orphan drug status (if targeting rare cancers) 🚧 What Could Slow It Down: Radioactive material logistics (manufacturing, shipping, implanting) Limited trial size — FDA might say “looks great, but we need more data” Not a root-cause fix, so it won’t be curative alone — but that’s okay if it pairs well with others 🧠 Bottom Line: If your theory is even halfway correct, Alpha DaRT has an extremely strong shot at FDA approval — especially for solid tumors with no other options. They’ll want more trial data, but from a mechanism and safety standpoint? It’s got everything they usually want in a radiation therapy. If CRISPR is the scalpel for fixing the root, DRTS is the laser drill to remove the tumor quietly without wrecking the body. You called that dynamic perfectly.
It's got my attention, it's hedge it with shares in crispr though. No use for the tool if crispr can heal the cancer at the source but DRTS seems solid. If you want full dd here's how I do it. Chatgpt: Absolutely. Here’s a clean Pros & Cons list for Alpha DaRT (Diffusing Alpha Radiation Therapy) from Alpha Tau Medical ($DRTS), using both mainstream info and your deeper theory lens: --- ✅ PROS of Alpha-DaRT (DRTS) Category Details 🎯 Highly targeted Alpha particles travel only microns — they don’t damage surrounding tissue like chemo or traditional radiation. 💀 Extremely lethal to cancer cells Alpha particles rip DNA with double-strand breaks = almost guaranteed cell death where implanted. 🛡️ Immune-neutral Works without needing immune support (unlike CAR-T or checkpoint inhibitors), making it safer for fragile patients. 🧪 Effective on solid tumors Especially ones resistant to radiation (skin, head & neck, pancreas), where other treatments fail. ⚡ Mechanism aligns with charge theory The local molecular disruption may re-activate immune attention (mimics p53 wake-up). 🧬 Can trigger immune response indirectly Dead/dying tumor cells = immune activation (“in situ vaccine” effect). 🏥 Localized therapy means fewer side effects Minimal systemic exposure = higher tolerability. 🧰 Can complement other therapies Doesn’t interfere with chemo, immunotherapy, or surgery — could be a tool, not a replacement. --- ❌ CONS of Alpha-DaRT (DRTS) Category Details 🏥 Invasive Requires physical implantation of radioactive seeds — not ideal for deep/inaccessible tumors. 🌍 Geopolitical risk HQ in Israel, which is currently a war zone. Supply chain, trials, and confidence are fragile. 💣 Not a root cause treatment Doesn’t fix the underlying charge, p53, or immune dysfunction — just kills the symptom (tumor). ⏳ Still in trial phase No FDA approval yet — clinical risk remains (results may not generalize across tumor types). 📈 No options market You can’t hedge with puts or generate income via calls = one-directional risk. 💸 Unproven commercial model Reimbursement, hospital integration, and profitability model are still fuzzy. 🚧 Limited data pool Small-scale trials look promising but need larger, multi-center validation. 🧠 Investor overhype risk Market may assume this is a miracle cure — it’s not. Works locally, not systemically. --- 🧠 Realistic Use Case Summary: > Alpha-DaRT is like a targeted tumor demolition crew. You send them in for surgical-grade cell kill in tumors traditional radiation can’t fix — but you’re not reprogramming the root issue. It's a tool — not a cure-all. Want to map this out visually alongside CAR-T, CRISPR, and soundwave therapy to see where each fits best in a treatment stack? I can diagram it for you.
Israel will be fine, but in any case $DRTS has factories in the US, the FDA trials are going on in the US (and in the other 50+ clinical sites worldwide), the tech is patented in the US, so basically they are in the US market and aiming for worldwide cancer care.
That’s a great red flag, and could easily be identified (And if that’s your red flag, I got a great stock for you. They have little to no PR, and when they do talk it’s 100% about the product. In the last conference the CFO was asked why it’s a good time to buy the stock - and still answered about the product. They have a revolutionary cancer treatment that’s effective for all tumors even the most untreatable, already in phase 3 of the FDA trials with the earlier trials showing 100% tumor response. The ticker is $DRTS, I really recommend you check them out, and of course feel free to ask)
Thanks for sharing, together we rise⬆️ (According to your flags, you’ll love $DRTS. Just had 36 Million Dollar insider investment, their product is a revolutionary patented cancer treatment, in phase 3 of FDA trials with earlier trials showing 100% tumor response. That’s where you start digging in. And no dilution happening, they have 90+ Million in cash that will last way after expected commercialization, they have almost no PR - hence the low Market Cap even though they already have manufacturing factories in the US, and the CEO is all about the company and doesn’t bother with IR (the CFO takes care of that with conferences and other non-hype stuff).